Subscribe
The AI leader’s shares have been flat since the summer despite continued growth
Global data centre capacity is projected to double by 2030
The medical equipment manufacturer has been ailing, but its condition should stabilise
Incoming chair Kevin Warsh wants to shrink the Fed’s balance sheet and rethink quantitative easing
The Squeeze: Focusing on a single issue can blind investors in the long term
The company’s strong performance came while its fast food rivals have struggled
Pharma’s AI investment fits far better into the industry’s business model
The Analyst: Robin Hardy outlines the best options in a booming sector
The Squeeze: The company thinks it’s at the forefront of innovation, but it’s cutting R&D spending
There has been a rotation towards ‘real-world’ stocks as investors look to hide from AI disruption
